Juvederm Voluma with Lidocaine is a high-density hyaluronic acid filler designed for deep volumization, contour restoration, and structural lifting of the mid-face.
Formulated with Vycross™ technology, it combines low and high molecular weight HA to create a durable, smooth gel with exceptional lifting capacity. Ideal for treating cheeks, cheekbones, chin, and jawline, it provides long-lasting definition while preserving natural facial movement. Results typically last 18-24 months, depending on technique, anatomical area, and patient metabolism.
Rheological properties / Product data
HA concentration: 20 mg/ml
Cross-linking agent: BDDE
Elasticity (G′): High
Cohesivity: High
Texture: Monophasic Vycross™ gel
Lidocaine content: 0.3%
Injection depth & tools
Recommended depth: Deep dermis, subcutaneous, or supraperiosteal layer
Injection techniques: Bolus, micro-bolus, linear threading
Recommended instruments: 27G needle or 25G cannula
Inject slowly under aseptic conditions; aspirate before each injection to minimize intravascular risk.
Storage & handling
Store at 2 °C - 25 °C, protected from heat and sunlight
Do not freeze
Single-use only - discard after opening
Dispose of syringes and needles according to local medical waste regulations
For licensed medical practitioners only. Not for self-injection.
Not advised during breastfeeding—limited data on transfer via milk and infant safety; postpone elective procedures.
Patients should avoid alcohol 24 hours before and after treatment to prevent excessive vasodilation, bruising, and swelling.
Contraindicated during pregnancy. There are no controlled studies evaluating the safety of dermal fillers in pregnant women. All elective aesthetic procedures should be postponed until after childbirth.
Inject into the deep dermis or subcutaneous layer using bolus, fanning, or linear threading technique depending on anatomical area and desired projection. Typical volume per side is 0.5–1 ml, adjusted to clinical indication and symmetry. Always aspirate prior to injection and administer slowly to minimize the risk of intravascular compromise. Maintain sterile conditions throughout.
Common post-injection reactions include mild redness, swelling, tenderness, or bruising, typically resolving within several days. Rare but significant adverse effects such as vascular occlusion, blanching, pain, or visual symptoms require immediate medical intervention. Applying cold compresses and avoiding direct heat or massage for 24–48 hours helps minimize local inflammation.
The filler’s cross-linked hyaluronic acid restores lost facial volume and supports mid-face lifting by binding and retaining water molecules within the tissue. Its Vycross™ technology combines low- and high-molecular-weight HA chains, enhancing gel durability and resistance to degradation while ensuring a smooth, natural integration into the dermal matrix. Over time, the product biodegrades gradually without residue, leaving improved skin quality and elasticity.
Cross-linked Hyaluronic Acid (20 mg/ml) and Lidocaine (0.3%) for analgesia and patient comfort. Non-animal derived HA, formulated with Vycross™ technology to ensure high cohesivity, precision placement, and longevity of results.
